Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown, New Jersey, United States is listed as a site for 216 registered clinical trials, 188 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 216
Ongoing 188

This page covers the site record Memorial Sloan Kettering Monmouth (Limited Protocol Activities) in Middletown, New Jersey, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Memorial Sloan Kettering Monmouth (Limited Protocol Activities) report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 216 trials counted.

  • Phase 1 50 trials
  • Phase 1/2 19 trials
  • Phase 2 111 trials
  • Phase 3 4 trials
  • Phase 4 2 trials
  • Not applicable 19 trials
  • Observational 11 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 188 trials
  • Completed 22 trials
  • Terminated 6 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 33

2012: 1 trials (Observational 1) 2013: 1 trials (Phase 1 1) 2014: 2 trials (Observational 1, Phase 1/2 1) 2016: 2 trials (Phase 2 1, Phase 1 1) 2017: 3 trials (Observational 1, Phase 2 1, Phase 1 1) 2018: 7 trials (Phase 2 4, Phase 1/2 2, Phase 1 1) 2019: 8 trials (Not applicable 1, Phase 2 3, Phase 1/2 2, Phase 1 2) 2020: 22 trials (Phase 2 15, Phase 1/2 3, Phase 1 4) 2021: 30 trials (Observational 1, Not applicable 3, Phase 3 1, Phase 2 12, Phase 1/2 2, Phase 1 11) 2022: 26 trials (Observational 1, Not applicable 3, Phase 2 17, Phase 1/2 1, Phase 1 4) 2023: 33 trials (Observational 2, Not applicable 3, Phase 3 1, Phase 2 21, Phase 1/2 1, Phase 1 5) 2024: 28 trials (Observational 3, Not applicable 4, Phase 3 1, Phase 2 13, Phase 1/2 1, Phase 1 6) 2025: 29 trials (Not applicable 2, Phase 4 2, Phase 3 1, Phase 2 11, Phase 1/2 5, Phase 1 8)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 24
2025 29
2024 28
2023 33
2022 26
2021 30
2020 22
2019 8
2018 7
2017 3

Showing 10 of 14 years.

Start your 14-day trial Email me all 14 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 216 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 127 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF